Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (5721)	10/5/1998 6:27:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 9719

Rman: Nice commentary. We need to gather people from the various threads.... INCY, HYSQ, AFFX and others that are relevant..... Poodle, Dr. Goodhybe, and several others..... and get an understanding of the fundamental claims and how they'll stand up. I always just avoided the issues, but now that Incyte owns Synteni, I either need to know the stuff or get out. I'm not just concerned about the sales of tools for drug research, but the actual right to practice an art in the course of drug discovery. That release today wasn't very satisfying. Not much to munch on. What's up? Rick

To: Rocketman who wrote (5721)	10/5/1998 11:13:00 PM
From: JF Quinnelly	Read Replies (1) \| Respond to of 9719

Hey, Rman. I wander back for a look and find you dudes are getting back to my favorites, the gene chippers. Take a look at the weekly AFFX and INCY charts, they are riding out this latest market debacle and seem to be in a rising pattern. They both appear to be bumping up against their long term trend lines, and if they break through it will be an excellent sign, especially in this market. And what the hell is happening to our herd of transgenic goats and mice? Did the milking machines break down? Do I dare double up on GZTC here, or is this gonna be a dead end?